Antithrombotic and thrombosis-eliminating preparation
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of antithrombotic and antithrombotic preparations, which is applied in the field of antithrombotic and antithrombotic preparations, can solve the problems of large side effects, unsatisfactory effects, and easy to cause vascular bleeding, etc., to prevent blood coagulation, prevent microthrombus re-formation, and improve microcirculation blood The effect of velocity
Active Publication Date: 2011-09-28
海城市中医院
View PDF1 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
In the acute stage of ischemic stroke, thrombolytic therapy can generally be performed within 3 hours, but most patients have already missed the thrombolytic time when they come to the hospital, and can only be treated with calcium ion antagonists and brain protective agents to prevent platelet aggregation. The effect is often unsatisfactory. At present, the commonly used thrombolytic drugs include rt-PA or urokinase, which have relatively large side effects and easily cause vascular bleeding.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] Preparation of concentrated water decoction of medicine of the present invention
[0033] Take 30g of astragalus, 5g of leech, 15g of safflower, 15g of red peony root, 10g of salvia miltiorrhiza, 15g of peach kernel, add water to the raw materials together to 600ml, soak for 30 minutes, decoct and concentrate to 300ml, and take it orally in 3 times (daily amount) .
Embodiment 2
[0035] The concentrated pill preparation of medicine of the present invention
[0036] Take 350g of astragalus, 50g of leech, 140g of safflower, 140g of red peony root, 140g of salvia miltiorrhiza, and 140g of peach kernel, wash and dry the raw materials, then crush, sterilize, and sieve. Add 960g of honey and 1920g of combined lumps to obtain 320 pills, each 6g.
Embodiment 3
[0038] The powder capsule preparation of medicine of the present invention
[0039] Take 30g of astragalus, 3g of leech, 10g of safflower, 10g of red peony root, 15g of salvia miltiorrhiza, and 10g of peach kernel, wash and dry the medicine, then crush, sterilize, and sieve. Take a total of 78g of medicine, 15% of the consumption, and 66g of the net. 110 hollow capsules are evenly distributed, each capsule is 0.6g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to an antithrombotic and thrombosis-eliminating preparation, which is characterized by being prepared from the following raw material medicines in part by weight: 30 to 60 parts of astragalus, 3 to 6 parts of leech, 10 to 20 parts of safflower, 10 to 20 parts of red paeony root, 5 to 15 parts of root of red-rooted salvia and 10 to 20 parts of peach kernel. Compared with the prior art, the antithrombotic and thrombosis-eliminating preparation has the advantages that: based on the acute phase formation characteristics and pathological change of ishemic stroke, a compound Chinese medicine with effects of scattering and eliminating stasis, promoting dieresis and diminishing swelling is used to treat acute ishemic stroke; and lots of clinic tests prove that the antithrombotic and thrombosis-eliminating preparation has obvious treatment effects of preventing blood clotting, dissolving blood clots, expanding blood capillaries, relieving arteriospasm, lowering blood viscosity, improving flowing speed of microcirculating blood.
Description
technical field [0001] The invention relates to an antithrombotic and antithrombotic preparation for treating stroke. Background technique [0002] Stroke is also called stroke, which is divided into ischemic stroke and hemorrhagic stroke. Stroke is a general term for acute cerebrovascular diseases in traditional Chinese medicine. At present, the incidence of stroke is increasing year by year with the change of environment and diet structure, and the disability and death rate is quite high, which brings burden and economic loss to the family and society. Therefore, the research and treatment of stroke is a topic of general concern in the medical field. In the acute stage of ischemic stroke, thrombolytic therapy can generally be performed within 3 hours, but most patients have already missed the thrombolytic time when they come to the hospital, and can only be treated with calcium ion antagonists and brain protective agents to prevent platelet aggregation. The effect is ofte...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more